IRIS Accounts Production v24.2.0.383 10708999 Board of Directors 1.4.23 31.3.24 31.3.24 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh107089992023-03-31107089992024-03-31107089992023-04-012024-03-31107089992022-03-31107089992022-04-012023-03-31107089992023-03-3110708999ns15:EnglandWales2023-04-012024-03-3110708999ns14:PoundSterling2023-04-012024-03-3110708999ns10:Director12023-04-012024-03-3110708999ns10:PrivateLimitedCompanyLtd2023-04-012024-03-3110708999ns10:SmallEntities2023-04-012024-03-3110708999ns10:AuditExempt-NoAccountantsReport2023-04-012024-03-3110708999ns10:SmallCompaniesRegimeForDirectorsReport2023-04-012024-03-3110708999ns10:SmallCompaniesRegimeForAccounts2023-04-012024-03-3110708999ns10:FullAccounts2023-04-012024-03-311070899912023-04-012024-03-3110708999ns10:Director22023-04-012024-03-3110708999ns10:RegisteredOffice2023-04-012024-03-3110708999ns5:CurrentFinancialInstruments2024-03-3110708999ns5:CurrentFinancialInstruments2023-03-3110708999ns5:Non-currentFinancialInstruments2024-03-3110708999ns5:Non-currentFinancialInstruments2023-03-3110708999ns5:ShareCapital2024-03-3110708999ns5:ShareCapital2023-03-3110708999ns5:RetainedEarningsAccumulatedLosses2024-03-3110708999ns5:RetainedEarningsAccumulatedLosses2023-03-3110708999ns5:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3110708999ns5:DevelopmentCostsCapitalisedDevelopmentExpenditure2023-04-012024-03-3110708999ns5:PlantMachinery2023-04-012024-03-3110708999ns5:IntangibleAssetsOtherThanGoodwill2023-03-3110708999ns5:IntangibleAssetsOtherThanGoodwill2024-03-3110708999ns5:IntangibleAssetsOtherThanGoodwill2023-03-3110708999ns5:PlantMachinery2023-03-3110708999ns5:PlantMachinery2024-03-3110708999ns5:PlantMachinery2023-03-3110708999ns5:AdditionsToInvestments2024-03-3110708999ns5:CostValuation2024-03-3110708999ns5:CurrentFinancialInstrumentsns5:WithinOneYear2024-03-3110708999ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-03-31
REGISTERED NUMBER: 10708999 (England and Wales)








Unaudited Financial Statements

for the Year Ended 31 March 2024

for

MEDISALE LIMITED

MEDISALE LIMITED (REGISTERED NUMBER: 10708999)






Contents of the Financial Statements
for the year ended 31 March 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


MEDISALE LIMITED

Company Information
for the year ended 31 March 2024







DIRECTORS: Ms L A Telka
A J Telka





REGISTERED OFFICE: Unit 1 Cambridge Mills
Cambridge
Gloucester
GL2 7AA





REGISTERED NUMBER: 10708999 (England and Wales)





ACCOUNTANTS: Mitchell Glanville (Bristol) Limited
c/o MGB Accountants - Suite 22
Trym Lodge, 1 Henbury Road
Westbury-on-Trym
Bristol
BS9 3HQ

MEDISALE LIMITED (REGISTERED NUMBER: 10708999)

Balance Sheet
31 March 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 778 1,627
Tangible assets 5 8,570 13,157
Investments 6 4,800 -
14,148 14,784

CURRENT ASSETS
Stocks 521,528 709,582
Debtors 7 20,656 39,604
Cash at bank 381,918 156,971
924,102 906,157
CREDITORS
Amounts falling due within one year 8 315,164 435,147
NET CURRENT ASSETS 608,938 471,010
TOTAL ASSETS LESS CURRENT
LIABILITIES

623,086

485,794

CREDITORS
Amounts falling due after more than one year 9 28,291 39,433
NET ASSETS 594,795 446,361

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 594,695 446,261
594,795 446,361

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 11 October 2024 and were signed on its behalf by:





A J Telka - Director


MEDISALE LIMITED (REGISTERED NUMBER: 10708999)

Notes to the Financial Statements
for the year ended 31 March 2024

1. STATUTORY INFORMATION

Medisale Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Development costs are being amortised evenly over their estimated useful life of four years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 25% on cost

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 12 (2023 - 10 ) .

MEDISALE LIMITED (REGISTERED NUMBER: 10708999)

Notes to the Financial Statements - continued
for the year ended 31 March 2024

4. INTANGIBLE FIXED ASSETS
Other
intangible
assets
£   
COST
At 1 April 2023
and 31 March 2024 3,395
AMORTISATION
At 1 April 2023 1,768
Charge for year 849
At 31 March 2024 2,617
NET BOOK VALUE
At 31 March 2024 778
At 31 March 2023 1,627

5. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 April 2023 31,867
Additions 3,201
At 31 March 2024 35,068
DEPRECIATION
At 1 April 2023 18,710
Charge for year 7,788
At 31 March 2024 26,498
NET BOOK VALUE
At 31 March 2024 8,570
At 31 March 2023 13,157

6. FIXED ASSET INVESTMENTS
Other
investments
£   
COST
Additions 4,800
At 31 March 2024 4,800
NET BOOK VALUE
At 31 March 2024 4,800

7. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 8,488 -
Other debtors 12,168 39,604
20,656 39,604

MEDISALE LIMITED (REGISTERED NUMBER: 10708999)

Notes to the Financial Statements - continued
for the year ended 31 March 2024

8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Bank loans and overdrafts 7,007 8,925
Trade creditors 57,349 293,853
Taxation and social security 249,351 132,132
Other creditors 1,457 237
315,164 435,147

9. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
2024 2023
£    £   
Bank loans 28,291 39,433